Annual report pursuant to Section 13 and 15(d)

Nature of Operations and Business Activities (Details)

v3.23.1
Nature of Operations and Business Activities (Details)
12 Months Ended
Dec. 30, 2022
Nov. 17, 2022
Oct. 17, 2022
USD ($)
Dec. 31, 2022
USD ($)
employee
Dec. 31, 2021
USD ($)
Nov. 10, 2022
Nature Of Operations And Business Activities [Line Items]            
Working capital deficit       $ 3,175,408    
Accumulated deficit       (66,737,765) $ (47,256,163)  
Cash and cash equivalents       1,244,527 8,983,007  
Operating loss       $ 18,311,732 $ 7,847,714  
Emerald Health Therapeutics Inc            
Nature Of Operations And Business Activities [Line Items]            
Exchange ratio           1.95
Number of employees laid off | employee       2    
Working capital loan     $ 700,000 $ 700,000    
Multi-Draw Credit Agreement            
Nature Of Operations And Business Activities [Line Items]            
Total principal value of convertible debt—related party       $ 1,848,375    
Percent of principal prepaid 25.00% 25.00%